How to Verify Your Retatrutide Source
Before injecting anything into your body, you need to know where it came from and whether it is what it claims to be. Here is a step-by-step verification process for retatrutide sources.
The gap between retatrutide's extraordinary Phase 2 results (Jastreboff et al., NEJM 2023) and its current unavailability as an FDA-approved drug has created a market filled with sources of varying legitimacy. Some are licensed compounding pharmacies producing quality products. Others are unregulated vendors selling untested chemicals. Telling them apart requires knowing what to look for and what questions to ask.
Safety First
Retatrutide is not FDA-approved. Always work with a licensed healthcare provider and use only licensed pharmacy sources. This guide helps you evaluate sources but does not endorse any specific pharmacy.
Step 1: Verify Pharmacy Licensure
Every legitimate compounding pharmacy must be licensed by their state board of pharmacy. You can verify this by visiting your state's board of pharmacy website (or the pharmacy's home state) and searching for their license number. The pharmacy should prominently display their license information. If they do not have a verifiable state pharmacy license, stop -- they are not a legitimate pharmacy.
Step 2: Confirm Sterile Compounding Capability
Injectable medications must be compounded in USP 797-compliant sterile environments. Ask the pharmacy whether they have a certified clean room, conduct environmental monitoring, and perform sterility testing on finished products. Not all pharmacies that dispense oral medications are equipped for sterile compounding.
Step 3: Request Certificate of Analysis
What a CoA Should Include
Identity Confirmation
Test confirming the substance is retatrutide (mass spectrometry or specific assay)
Purity by HPLC
Should be 98% or higher; lower purity indicates significant impurities
Potency Assay
Confirms concentration matches the label claim (within 90-110% of stated amount)
Sterility Test
Confirms no bacterial or fungal growth (essential for injectables)
Endotoxin Test (LAL)
Confirms bacterial endotoxin levels are below safe limits
Testing Laboratory
Third-party lab is preferable to in-house testing for independence
Step 4: Evaluate Red Flags
Warning Signs
- No prescription required for purchase
- Product labeled "for research use only" or "not for human consumption"
- No verifiable US pharmacy license
- Cannot or will not provide a certificate of analysis
- Prices dramatically below market (often indicates quality shortcuts)
- Payment by cryptocurrency or wire transfer only
- No physical US address or contact phone number
- Claims that retatrutide is FDA-approved (it is not)
- Aggressive marketing with unsubstantiated claims
Step 5: Involve Your Healthcare Provider
A prescribing physician should be involved in any retatrutide access pathway. Telehealth providers who specialize in weight loss medications often have established relationships with vetted compounding pharmacies, providing an additional layer of quality assurance. Your provider can also monitor your treatment with appropriate lab work and clinical follow-up.
To explore verified weight loss treatment options, visit our treatments page.
Medical Disclaimer
This article is for educational purposes only. Retatrutide is not FDA-approved. This guide does not endorse any specific pharmacy or source. Always work with a licensed healthcare provider. Consult your physician before starting any medication.
Verified Weight Loss Treatment
Skip the uncertainty. Semaglutide from $99/mo and tirzepatide from $125/mo with medical oversight.
Get Started TodayMore on Retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).